Home » Stocks » Stryker

Stryker Corporation (SYK)

Stock Price: $189.47 USD -2.08 (-1.08%)
Updated Aug 10, 2020 2:22 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 71.16B
Revenue (ttm) 14.07B
Net Income (ttm) 1.60B
Shares Out 375.61M
EPS (ttm) 4.21
PE Ratio 45.00
Forward PE 28.33
Dividend $2.30
Dividend Yield 1.21%

Stock Quote

Trading Day Aug 10, 2020
Last Price $189.47
Previous Close $191.54
Change ($) -2.08
Change (%) -1.08%
Day's Open 191.39
Day's Range 189.15 - 192.02
Day's Volume 387,090
52-Week Range 124.54 - 226.30

More Stats

Market Cap 71.16B
Enterprise Value 77.47B
Earnings Date (est) Oct 22, 2020
Ex-Dividend Date Jun 29, 2020
Shares Outstanding 375.61M
Float 331.95M
EPS (basic) 4.28
EPS (diluted) 4.21
FCF / Share 5.22
Dividend $2.30
Dividend Yield 1.21%
Earnings Yield 2.22%
FCF Yield 2.75%
Payout Ratio 52.50%
Shares Short 3.45M
Short Ratio 2.07
Short % of Float 1.04%
Beta 0.85
PE Ratio 45.00
Forward PE 28.33
P/FCF Ratio 36.31
PS Ratio 5.06
PB Ratio 5.55
Revenue 14.07B
Operating Income 2.19B
Net Income 1.60B
Free Cash Flow 1.96B
Net Cash -6.30B
Net Cash / Share -16.78
Gross Margin 69.66%
Operating Margin 15.54%
Profit Margin 11.40%
FCF Margin 13.93%
ROA 6.31%
ROE 12.97%
ROIC 10.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (27)

Buy 13
Overweight 2
Hold 9
Underweight 1
Sell 2

Analyst Consensus: Overweight

Price Target

$214.39*
(13.16% upside)
Low
155
Current: $189.47
High
245
Target: 214.39
*Average 12-month price target from 23 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue14,88413,60112,44411,3259,9469,6759,0218,6578,3077,320
Revenue Growth9.43%9.3%9.88%13.86%2.8%7.25%4.2%4.21%13.48%-
Gross Profit9,6968,9388,1807,5046,6026,3566,0195,8765,4965,034
Operating Income2,7132,5372,2972,1751,8611,2461,2561,7411,6861,751
Net Income2,0833,5531,0201,6471,4395151,0061,2981,3451,273
Shares Outstanding374374374374377379379381387396
Earnings Per Share5.489.342.684.353.781.342.633.393.453.19
EPS Growth-41.33%248.51%-38.39%15.08%182.09%-49.05%-22.42%-1.74%8.15%-
Dividend Per Share2.141.931.751.571.421.261.100.900.750.63
Dividend Growth10.62%10.6%11.5%10.6%12.3%14.55%21.82%20.08%19.37%-
Operating Cash Flow2,1912,6101,5591,9159811,7821,8861,6571,4341,547
Capital Expenditures-649-572-598-490-270-233-195-210-159-121
Free Cash Flow1,5422,0389611,4257111,5491,6911,4471,2751,426
Cash & Equivalents4,4253,6992,7933,3844,0795,0003,9804,2853,4184,380
Total Debt11,0909,8597,2226,9143,9983,9732,7641,7621,7681,021
Net Cash / Debt-6,665-6,160-4,429-3,53081.001,0271,2162,5231,6503,359
Assets30,16727,22922,19720,43516,22317,27915,74313,20612,14610,895
Liabilities17,36015,49912,21710,8857,7128,6846,6964,6094,4633,721
Book Value12,80711,7309,9669,5508,5118,5959,0478,5977,6837,174
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Stryker Corporation
Country United States
Employees 40,000
CEO Kevin A. Lobo

Stock Information

Ticker Symbol SYK
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: SYK

Description

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.